Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myelodysplastic syndromes
Huan Li, Fang‐Wen Hu, Robert Peter Gale, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Improved Side Effect Profile of Alternate-Day Dosing of Lenalidomide
R.A. Lawal, Oluwole Banjoko, Chukwunonso Ndulue, et al.
Cureus (2024)
Open Access
RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway
Ji Zhang, Li Liu, Chaoying Yang, et al.
Research Square (Research Square) (2024)
Open Access
Case report: A successful clinical experience of transplantation of liver and kidney from a donor with myelodysplastic syndromes
Kang Huang, Qiuyan Zhang, Sanyun Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice
Letícia Rodrigues Sampaio, Ricardo Dyllan Barbosa Dias, João Vitor Caetano Goes, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access
Implementation of advanced analytical methods MeD-seq and LC-MS/MS for assessing the epigenetic profile of high-risk myelodysplastic syndrome
Theodoros Nikolopoulos, Eleftherios Bochalis, Theodora Chatzilygeroudi, et al.
Research Square (Research Square) (2024)
Open Access
Spontaneous Splenic Rupture in a Patient with Myelodysplastic Syndrome
Manuel Flores Sáenz
Revista de la Facultad de Medicina de la Universidad de lberoamérica (2024) Vol. 1, Iss. 2, pp. 31-38
Open Access
Complete Blood Counts and Research Parameters in the Detection of Myelodysplastic Syndromes
Eloísa Urrechaga, Mónica Fernández, Urko Aguirre
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1322-1322
Open Access
Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis
Xueya Han, Wei Liu, Zhong-Yu Kang, et al.
Annals of Hematology (2024)
Closed Access
A Case of Typhoid Fever with Myelodysplastic Syndrome Resulting in Severe Pancytopenia
Deepak Singla, Devis Cherian, Mishu Mangla, et al.
Journal of Medical Evidence (2024) Vol. 5, Iss. 3, pp. 246-247
Open Access
Synthetic Routes and Clinical Application of New Drugs Approved by EMA During 2023
Yu Xia, Qingqing Chen, Henan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116762-116762
Closed Access
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
CCL17, CCL22 and their receptor CCR4 in hematologic malignancies
Shasha Zou, Bo Liu, Yonghuai Feng
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Comprehensive analysis of a necroptosis-associated diagnostic signature for myelodysplastic syndromes based on single-cell RNA-seq and bulk RNA-seq
Huimin Zhang, Li Zhang, Xiaoning Liang, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access
Improvement in quality of life in MDS patients who become transfusion independent after treatment
Betty Wan, Shabbir M.H. Alibhai, Lisa Chodirker, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-10
Closed Access
Sintilimab plus decitabine for higher-risk treatment-naïve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trial
Jing Wang, Siqi Li, Hao Jiang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010355-e010355
Open Access
A novel therapeutic strategy for leukopenia: miltefosine activates the Ras/MEK/ERK pathway to promote neutrophil differentiation
Qinyao Li, Siyu He, Zhichao Li, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 746, pp. 151239-151239
Closed Access
A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients
Ludan Zhang, Rui Ge, Deng Pan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
Meiwan Cao, Baoling Peng, Wanfu Xu, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023040-e2023040
Open Access | Times Cited: 1
Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature
Nuan-Nuan Xiu, Xiaodong Yang, Jia Xu, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 28, pp. 6908-6919
Open Access | Times Cited: 1
Multiparameter Flow Cytometry: An Important Auxiliary Tool for The Diagnosis and Differential Diagnosis of Myelodysplastic Neoplasms
Siqi Luo, Rong Huang, Shifeng Lou
Diseases & Research (2023) Vol. 3, Iss. 1, pp. 55-64
Open Access
Dysregulated expression ofHoxa1isoforms in hematopoietic stem and progenitor cells causes myelodysplastic syndromes
ShuhYing Tan, Chacko Joseph, Alistair M. Chalk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Previous Page - Page 2

Scroll to top